Literature DB >> 12375666

Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion.

Miki Yamaguchi1, Fumiya Hirayama, Shinobu Wakamoto, Mitsuhiro Fujihara, Hideaki Murahashi, Norihiro Sato, Kenji Ikebuchi, Ken-ichi Sawada, Takao Koike, Mikinori Kuwabara, Hiroshi Azuma, Hisami Ikeda.   

Abstract

BACKGROUND: An ex vivo culture system was previously established for stem cell expansion using human marrow stromal cells and serum-free medium. However, the stromal cells were prepared using long-term culture medium containing horse serum and FCS, which may transmit infectious diseases of xenogeneic origin. In this study, therefore, a method was established to prepare stromal cells using an AB serum-based medium. In the case that serum from a transplant recipient or PBPC donor is available, additional infectious diseases would not be transmitted. STUDY DESIGN AND METHODS: Cord blood CD34+ cells were cultured with thrombopoietin, stem cell factor, and flt3/flk2 ligand on a monolayer of human marrow primary stromal cells prepared using long-term culture medium or AB serum-based medium. After 2 weeks, clonogenic progenitor activity and SCID mouse-reconstituting cell activity were assayed. mRNA expression of cytokines and Notch ligand by stromal cells was also examined.
RESULTS: There were no remarkable differences in expansion-supporting activity and mRNA expression between stromal cells established by the two methods.
CONCLUSION: An ex vivo expansion system completely based on AB serum has been established.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12375666     DOI: 10.1046/j.1537-2995.2002.00149.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  18 in total

1.  Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.

Authors:  Karen Bieback; Katharina Schallmoser; Harald Klüter; Dirk Strunk
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

2.  Derivation, expansion and characterization of clinical grade mesenchymal stem cells from umbilical cord matrix using cord blood serum.

Authors:  Khushnuma Cooper; Anish SenMajumdar; Chandra Viswanathan
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

3.  Mesenchymal Progenitor Cells: Tissue Origin, Isolation and Culture.

Authors:  Philippe Bourin; Mélanie Gadelorge; Julie-Anne Peyrafitte; Sandrine Fleury-Cappellesso; Marilyn Gomez; Christine Rage; Luc Sensebé
Journal:  Transfus Med Hemother       Date:  2008-05-08       Impact factor: 3.747

4.  Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells.

Authors:  Smruti M Phadnis; Mugdha V Joglekar; Vijayalakshmi Venkateshan; Surendra M Ghaskadbi; Anandwardhan A Hardikar; Ramesh R Bhonde
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Nov-Dec       Impact factor: 2.416

5.  "Humanized" stem cell culture techniques: the animal serum controversy.

Authors:  Chandana Tekkatte; Gency Ponrose Gunasingh; K M Cherian; Kavitha Sankaranarayanan
Journal:  Stem Cells Int       Date:  2011-04-03       Impact factor: 5.443

6.  Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans.

Authors:  Norihisa Sakamoto; Kazuhide Tsuji; Linda M Muul; Ann M Lawler; Emanuel F Petricoin; Fabio Candotti; Julia A Metcalf; Jorge A Tavel; H Clifford Lane; Walter J Urba; Bernard A Fox; Ajit Varki; Joan K Lunney; Amy S Rosenberg
Journal:  Blood       Date:  2007-03-29       Impact factor: 22.113

Review 7.  Ex vivo expansion of cord blood.

Authors:  S S Kelly; C B S Sola; M de Lima; E Shpall
Journal:  Bone Marrow Transplant       Date:  2009-10-05       Impact factor: 5.483

8.  Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials.

Authors:  Bourin Philippe; Sensebé Luc; Planat-Bénard Valérie; Roncalli Jérôme; Bura-Rivière Alessandra; Casteilla Louis
Journal:  Stem Cells Int       Date:  2010-10-31       Impact factor: 5.443

9.  Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease.

Authors:  Partow Kebriaei; Simon Robinson
Journal:  Front Oncol       Date:  2011-07-04       Impact factor: 6.244

Review 10.  Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.

Authors:  Ratti Ram Sharma; Kathryn Pollock; Allison Hubel; David McKenna
Journal:  Transfusion       Date:  2013-10-16       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.